首页> 外国专利> METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION WITH CARBAMYLATED DARBEPOETIN IN ADMA-LIKE MODEL OF PREECLAMPSIA

METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION WITH CARBAMYLATED DARBEPOETIN IN ADMA-LIKE MODEL OF PREECLAMPSIA

机译:类脂溢性痴呆模型中氨基甲酸酯化的内皮素对血管内皮功能障碍的纠正方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to experimental pharmacology. Pre-eclampsia model is reproduced in Wistar rats daily from 14 to 20 of pregnancy by intraperitoneal introduction of L-nitro-arginine-methyl ester 25 mg/kg. To correct simulated endothelial dysfunction, carbamylated darbepoetin 300 mcg/kg is injected subcutaneously once day on 7th, 10th, 13th, 16th and 19th day of pregnancy.;EFFECT: method enables correcting endothelial dysfunction in a simulated pathology in pregnant rats by pronounced antiischemic and antioxidant actions of carbamylated darbepoetin.;1 cl, 1 tbl, 1 ex
机译:技术领域:发明:药物是指医学,即实验药理学。通过在腹腔内引入25mg / kg的L-硝基-精氨酸甲酯,每天从妊娠14至20天在Wistar大鼠中复制子痫前期模型。为了纠正模拟的血管内皮功能障碍,在妊娠的第7、10、13、16和19天每天一次皮下注射氨基甲酸酯化的达比泊汀300 mcg / kg;效果:该方法能够通过明显的抗缺血和缺血作用纠正模拟大鼠的内皮功能障碍。氨基甲酸酯化达比泊汀的抗氧化作用。; 1 cl,1 tbl,1 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号